Machine learning ‐based model constructed from ultrasound radiomics and clinical features for predicting HER2 status in breast cancer patients with indeterminate (2+) immunohistochemical results

ConclusionsMachine learning models grounded on radiomics efficiently predicted IHC HER2 2+ status in breast cancer patients, suggesting potential enhancements in clinical decision-making for treatment and management.

Source: Cancer Medicine - January 18, 2024 Category: Cancer & Oncology Authors: Meiying Yan, Jincao Yao, Xiao Zhang, Dong Xu, Chen Yang Tags: RESEARCH ARTICLE Source Type: research